 |
| Schematic diagram of the "PAM 1" imaging system used in the 29-patient clinical trial. The Twente researchers are hoping to begin tests with their new "PAM 2" system - featuring 755nm in addition to 1064nm laser wavelengths - by the end of this year. Image: Nature Scientific Reports via Creative Commons Attribution 4.0 International License. |
| © 2024 SPIE Europe |
|
